American Association for the Advancement of Science, Science Translational Medicine, 542(12), 2020
DOI: 10.1126/scitranslmed.aay9355
Full text: Unavailable
Heterogenous immune reconstitution and de novo priming of HIV-specific T cells characterize allo-HSCT recovery in HIV-infected individuals.